Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission : a multicenter study from the EBMT PDWP
Contributors
Willasch, Andre ManfredPublished in
Bone marrow transplantation, vol. 61, no. 1, p. 67-74Publication date
2026-01First online date
2025-10-28Abstract
Keywords
- Child, Preschool
- Female
- Humans
- Infant
- Male
- Allografts
- Busulfan / pharmacology
- Busulfan / therapeutic use
- Busulfan / administration & dosage
- Cyclophosphamide / pharmacology
- Cyclophosphamide / therapeutic use
- Disease-Free Survival
- Hematopoietic Stem Cell Transplantation / methods
- Leukemia, Myeloid, Acute / therapy
- Leukemia, Myeloid, Acute / mortality
- Melphalan / pharmacology
- Melphalan / therapeutic use
- Melphalan / administration & dosage
- Remission Induction
- Transplantation Conditioning / methods
- Transplantation, Homologous / methods
- Treatment Outcome
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
WILLASCH, Andre Manfred et al. Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission : a multicenter study from the EBMT PDWP. In: Bone marrow transplantation, 2026, vol. 61, n° 1, p. 67–74. doi: 10.1038/s41409-025-02734-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:196432
- DOI : 10.1038/s41409-025-02734-8
- PMID : 41152589
